High-risk patients with aggressive non-Hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience)

被引：0
|
作者：
Stavrik, S. Genadieva [1 ]
Cevreska, L. [1 ]
Stojanoski, Z. [1 ]
Pivkova, A. [1 ]
Stojanovik, A. [1 ]
Balkanov, S. Krstevska [1 ]
Karanfilski, O. [1 ]
Georgievski, B. [1 ]
机构：
[1] Univ Clin Ctr, Dept Hematol, Skopje, Macedonia
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [11] Remission status as a predictor of survival in autologous stem cell transplantation in patients with non-Hodgkin lymphoma - a single center experience
    Pinto, Ana Luisa
    Roque, Adriana
    Gomes, Marilia
    Cortesao, Emilia
    Espadana, Ana Isabel
    Sarmento, Ana Bela
    Geraldes, Catarina
    Ribeiro, M. Leticia
    BONE MARROW TRANSPLANTATION, 2018, 53 : 617 - 618
  • [12] Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    ADVANCES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION AND MOLECULAR THERAPY, 1998, 144 : 15 - 26
  • [13] Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (04) : 297 - 304
  • [14] Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience
    Nachbaur, D
    Oberaigner, W
    Fritsch, E
    Nussbaumer, W
    Gastl, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (01) : 43 - 49
  • [15] A large, single-centre experience with allogeneic stem cell transplantation for T-cell non-Hodgkin lymphoma
    Jacobsen, E.
    Aldridge, J.
    Kim, H.
    Ho, V.
    Cutler, C.
    Koreth, J.
    Fisher, D.
    Armand, P.
    Alyea, E.
    Freedman, A.
    Soiffer, R.
    Antin, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S248 - S248
  • [16] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 457 - 464
  • [17] Autologous stem cell transplantation for 149 aggressive non-Hodgkin's lymphoma patients
    Sperotto, A
    Patriarca, F
    Zaja, F
    Geromin, A
    Stocchi, R
    Tiribelli, M
    Damiani, D
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S86 - S86
  • [18] A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome
    Fanin, R
    Sperotto, A
    De Elvira, CR
    Zaja, F
    Stocchi, R
    Geromin, A
    Cerno, M
    Patriarca, F
    Canelles, MF
    Damiani, D
    Baccarani, M
    HAEMATOLOGICA, 2000, 85 (09) : 943 - 951
  • [19] Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission
    Vose, JM
    Rizzo, DJ
    Tao-Wu, J
    Armitage, JO
    Bashey, A
    Burns, LJ
    Christiansen, NP
    Freytes, CO
    Gale, RP
    Gibson, J
    Giralt, SA
    Herzig, RH
    Lemaistre, CF
    McCarthy, PL
    Nimer, SD
    Petersen, FB
    Schenkein, DP
    Wiernik, PH
    Wiley, YM
    Loberiza, FR
    Lazarus, HM
    van Biesen, K
    Horowitz, MM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 116 - 127
  • [20] How to select patient with aggressive non-Hodgkin lymphoma in first complete remission for autologous transplantation (single-center experience)
    Genadieva-Stavrik, S
    Cevreska, L
    Stojanoski, Z
    Pivkova, A
    Trajkova, S
    Georgievski, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S244 - S244
12345